Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

BLCO vs DBVT vs PRGO vs HSIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BLCO
Bausch + Lomb Corporation

Medical - Instruments & Supplies

HealthcareNYSE • CA
Market Cap$5.67B
5Y Perf.-6.5%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.+32.4%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-70.6%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.09B
5Y Perf.-17.7%

BLCO vs DBVT vs PRGO vs HSIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BLCO logoBLCO
DBVT logoDBVT
PRGO logoPRGO
HSIC logoHSIC
IndustryMedical - Instruments & SuppliesBiotechnologyDrug Manufacturers - Specialty & GenericMedical - Distribution
Market Cap$5.67B$1712.35T$1.61B$8.09B
Revenue (TTM)$5.21B$0.00$4.18B$13.18B
Net Income (TTM)$-219M$-168M$-1.82B$398M
Gross Margin55.9%34.2%29.1%
Operating Margin5.9%-4.1%5.8%
Forward P/E20.1x5.6x13.3x
Total Debt$5.37B$22M$3.97B$3.69B
Cash & Equiv.$383M$194M$532M$156M

BLCO vs DBVT vs PRGO vs HSICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BLCO
DBVT
PRGO
HSIC
StockMay 22May 26Return
Bausch + Lomb Corpo… (BLCO)10093.5-6.5%
DBV Technologies S.… (DBVT)100132.4+32.4%
Perrigo Company plc (PRGO)10029.4-70.6%
Henry Schein, Inc. (HSIC)10082.3-17.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: BLCO vs DBVT vs PRGO vs HSIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HSIC leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. BLCO and DBVT also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
BLCO
Bausch + Lomb Corporation
The Growth Play

BLCO is the clearest fit if your priority is growth exposure.

  • Rev growth 6.5%, EPS growth -13.3%, 3Y rev CAGR 10.6%
  • 6.5% revenue growth vs DBVT's -100.0%
Best for: growth exposure
DBVT
DBV Technologies S.A.
The Defensive Pick

DBVT is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
  • +110.4% vs PRGO's -51.2%
Best for: sleep-well-at-night
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Beta 1.18, yield 9.8%, current ratio 2.76x
  • Lower P/E (5.6x vs 13.3x)
  • 9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Best for: income & stability and defensive
HSIC
Henry Schein, Inc.
The Long-Run Compounder

HSIC carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 5.3% 10Y total return vs BLCO's -20.5%
  • 3.0% margin vs PRGO's -43.5%
  • Beta 0.73 vs BLCO's 1.39, lower leverage
  • 3.6% ROA vs DBVT's -89.0%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthBLCO logoBLCO6.5% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.6x vs 13.3x)
Quality / MarginsHSIC logoHSIC3.0% margin vs PRGO's -43.5%
Stability / SafetyHSIC logoHSICBeta 0.73 vs BLCO's 1.39, lower leverage
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)HSIC logoHSIC3.6% ROA vs DBVT's -89.0%

BLCO vs DBVT vs PRGO vs HSIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BLCOBausch + Lomb Corporation
FY 2025
Device Products
37.7%$1.9B
Over the Counter Products
36.0%$1.8B
Pharmaceutical Products
21.2%$1.1B
Branded and Other Generic Products
4.8%$243M
Other Revenues
0.4%$21M
DBVTDBV Technologies S.A.

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M

BLCO vs DBVT vs PRGO vs HSIC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRGOLAGGINGHSIC

Income & Cash Flow (Last 12 Months)

BLCO leads this category, winning 3 of 6 comparable metrics.

HSIC and DBVT operate at a comparable scale, with $13.2B and $0 in trailing revenue. HSIC is the more profitable business, keeping 3.0% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, BLCO holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBLCO logoBLCOBausch + Lomb Cor…DBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…HSIC logoHSICHenry Schein, Inc.
RevenueTrailing 12 months$5.2B$0$4.2B$13.2B
EBITDAEarnings before interest/tax$724M-$112M$58M$1.1B
Net IncomeAfter-tax profit-$219M-$168M-$1.8B$398M
Free Cash FlowCash after capex$4M-$151M$108M$561M
Gross MarginGross profit ÷ Revenue+55.9%+34.2%+29.1%
Operating MarginEBIT ÷ Revenue+5.9%-4.1%+5.8%
Net MarginNet income ÷ Revenue-4.2%-43.5%+3.0%
FCF MarginFCF ÷ Revenue+0.1%+2.6%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year+9.4%-7.2%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+66.7%+91.5%-56.4%+14.9%
BLCO leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 5 of 6 comparable metrics.

On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than BLCO's 17.5x.

MetricBLCO logoBLCOBausch + Lomb Cor…DBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…HSIC logoHSICHenry Schein, Inc.
Market CapShares × price$5.7B$1712.35T$1.6B$8.1B
Enterprise ValueMkt cap + debt − cash$10.7B$1712.35T$5.1B$11.6B
Trailing P/EPrice ÷ TTM EPS-15.59x-0.76x-1.14x21.56x
Forward P/EPrice ÷ next-FY EPS est.20.10x5.56x13.26x
PEG RatioP/E ÷ EPS growth rate6.84x
EV / EBITDAEnterprise value multiple17.50x7.42x10.87x
Price / SalesMarket cap ÷ Revenue1.11x0.38x0.61x
Price / BookPrice ÷ Book value/share0.86x0.66x0.55x1.79x
Price / FCFMarket cap ÷ FCF11.12x14.12x
PRGO leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

HSIC leads this category, winning 6 of 9 comparable metrics.

HSIC delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), DBVT scores 4/9 vs BLCO's 3/9, reflecting mixed financial health.

MetricBLCO logoBLCOBausch + Lomb Cor…DBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…HSIC logoHSICHenry Schein, Inc.
ROE (TTM)Return on equity-3.4%-130.2%-50.7%+8.2%
ROA (TTM)Return on assets-1.6%-89.0%-19.8%+3.6%
ROICReturn on invested capital+1.2%+3.7%+7.1%
ROCEReturn on capital employed+1.6%-145.7%+4.3%+9.8%
Piotroski ScoreFundamental quality 0–93444
Debt / EquityFinancial leverage0.82x0.13x1.35x0.77x
Net DebtTotal debt minus cash$5.0B-$172M$3.4B$3.5B
Cash & Equiv.Liquid assets$383M$194M$532M$156M
Total DebtShort + long-term debt$5.4B$22M$4.0B$3.7B
Interest CoverageEBIT ÷ Interest expense0.71x-189.82x-7.20x4.59x
HSIC leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HSIC five years ago would be worth $8,746 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricBLCO logoBLCOBausch + Lomb Cor…DBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…HSIC logoHSICHenry Schein, Inc.
YTD ReturnYear-to-date-4.1%+4.9%-13.5%-8.2%
1-Year ReturnPast 12 months+39.5%+110.4%-51.2%+5.9%
3-Year ReturnCumulative with dividends-13.0%+19.7%-58.1%-11.7%
5-Year ReturnCumulative with dividends-20.5%-69.1%-60.1%-12.5%
10-Year ReturnCumulative with dividends-20.5%-87.0%-77.7%+5.3%
CAGR (3Y)Annualised 3-year return-4.5%+6.2%-25.2%-4.0%
DBVT leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BLCO and HSIC each lead in 1 of 2 comparable metrics.

HSIC is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than BLCO's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLCO currently trades 84.0% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBLCO logoBLCOBausch + Lomb Cor…DBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…HSIC logoHSICHenry Schein, Inc.
Beta (5Y)Sensitivity to S&P 5001.39x1.26x1.18x0.73x
52-Week HighHighest price in past year$18.92$26.18$28.44$89.29
52-Week LowLowest price in past year$10.85$7.53$9.23$61.95
% of 52W HighCurrent price vs 52-week peak+84.0%+76.3%+41.2%+79.0%
RSI (14)Momentum oscillator 0–10046.948.160.939.1
Avg Volume (50D)Average daily shares traded412K252K3.4M1.2M
Evenly matched — BLCO and HSIC each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: BLCO as "Hold", DBVT as "Buy", PRGO as "Hold", HSIC as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 19.5% for BLCO (target: $19). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricBLCO logoBLCOBausch + Lomb Cor…DBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…HSIC logoHSICHenry Schein, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyHoldHold
Price TargetConsensus 12-month target$19.00$46.33$20.00$86.43
# AnalystsCovering analysts16153632
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises0101
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+10.5%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

PRGO leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). BLCO leads in 1 (Income & Cash Flow). 1 tied.

Best OverallPerrigo Company plc (PRGO)Leads 2 of 6 categories
Loading custom metrics...

BLCO vs DBVT vs PRGO vs HSIC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is BLCO or DBVT or PRGO or HSIC a better buy right now?

For growth investors, Bausch + Lomb Corporation (BLCO) is the stronger pick with 6.

5% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BLCO or DBVT or PRGO or HSIC?

On forward P/E, Perrigo Company plc is actually cheaper at 5.

6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — BLCO or DBVT or PRGO or HSIC?

Over the past 5 years, Henry Schein, Inc.

(HSIC) delivered a total return of -12. 5%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: HSIC returned +5. 3% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BLCO or DBVT or PRGO or HSIC?

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 73β versus Bausch + Lomb Corporation's 1. 39β — meaning BLCO is approximately 90% more volatile than HSIC relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — BLCO or DBVT or PRGO or HSIC?

By revenue growth (latest reported year), Bausch + Lomb Corporation (BLCO) is pulling ahead at 6.

5% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Henry Schein, Inc. grew EPS 7. 2% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, BLCO leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BLCO or DBVT or PRGO or HSIC?

Henry Schein, Inc.

(HSIC) is the more profitable company, earning 3. 0% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — BLCO leads at 54. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BLCO or DBVT or PRGO or HSIC more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 20. 1x for Bausch + Lomb Corporation — 14. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — BLCO or DBVT or PRGO or HSIC?

In this comparison, PRGO (9.

8% yield) pays a dividend. BLCO, DBVT, HSIC do not pay a meaningful dividend and should not be held primarily for income.

09

Is BLCO or DBVT or PRGO or HSIC better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, BLCO: -20. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BLCO and DBVT and PRGO and HSIC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BLCO is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; PRGO is a small-cap income-oriented stock; HSIC is a small-cap quality compounder stock. PRGO pays a dividend while BLCO, DBVT, HSIC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BLCO

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.